These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31511824)

  • 1. Recent Advances in the Pharmacological Activities of Dioscin.
    Yang L; Ren S; Xu F; Ma Z; Liu X; Wang L
    Biomed Res Int; 2019; 2019():5763602. PubMed ID: 31511824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections.
    Tao X; Yin L; Xu L; Peng J
    Pharmacol Res; 2018 Nov; 137():259-269. PubMed ID: 30315966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioscin: A review on pharmacological properties and therapeutic values.
    Bandopadhyay S; Anand U; Gadekar VS; Jha NK; Gupta PK; Behl T; Kumar M; Radha ; Shekhawat MS; Dey A
    Biofactors; 2022 Jan; 48(1):22-55. PubMed ID: 34919768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme.
    Lv L; Zheng L; Dong D; Xu L; Yin L; Xu Y; Qi Y; Han X; Peng J
    Food Chem Toxicol; 2013 Sep; 59():657-69. PubMed ID: 23871826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of monomethylated dioscin derivatives and their antitumor activities.
    Li M; Han X; Yu B
    Carbohydr Res; 2003 Jan; 338(2):117-21. PubMed ID: 12526835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in study of dioscin--a natural product].
    Xu LN; Wei YL; Peng JY
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(1):36-41. PubMed ID: 25993784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioscin and diosgenin: Insights into their potential protective effects in cardiac diseases.
    Li X; Liu S; Qu L; Chen Y; Yuan C; Qin A; Liang J; Huang Q; Jiang M; Zou W
    J Ethnopharmacol; 2021 Jun; 274():114018. PubMed ID: 33716083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analogues of diosgenyl saponins: synthesis and anticancer activity.
    Kaskiw MJ; Tassotto ML; Mok M; Tokar SL; Pycko R; Th'ng J; Jiang ZH
    Bioorg Med Chem; 2009 Nov; 17(22):7670-9. PubMed ID: 19819703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of bidesmosidic dihydrodiosgenin saponins bearing a 3-O-beta-chacotriosyl moiety.
    Zhang Y; Li Y; Zhu S; Guan H; Lin F; Yu B
    Carbohydr Res; 2004 Jul; 339(10):1753-9. PubMed ID: 15220085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solanum incanum and S. heteracanthum as sources of biologically active steroid glycosides: confirmation of their synonymy.
    Manase MJ; Mitaine-Offer AC; Pertuit D; Miyamoto T; Tanaka C; Delemasure S; Dutartre P; Mirjolet JF; Duchamp O; Lacaille-Dubois MA
    Fitoterapia; 2012 Sep; 83(6):1115-9. PubMed ID: 22579841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscin (saponin)-induced generation of reactive oxygen species through mitochondria dysfunction: a proteomic-based study.
    Wang Y; Che CM; Chiu JF; He QY
    J Proteome Res; 2007 Dec; 6(12):4703-10. PubMed ID: 17975908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway.
    Qi M; Yin L; Xu L; Tao X; Qi Y; Han X; Wang C; Xu Y; Sun H; Liu K; Peng J
    Pharmacol Res; 2016 Sep; 111():509-522. PubMed ID: 27431331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition.
    Tao X; Sun X; Yin L; Han X; Xu L; Qi Y; Xu Y; Li H; Lin Y; Liu K; Peng J
    Free Radic Biol Med; 2015 Jul; 84():103-115. PubMed ID: 25772012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dioscin ameliorates intestinal ischemia/reperfusion injury via adjusting miR-351-5p/MAPK13-mediated inflammation and apoptosis.
    Zheng L; Han X; Hu Y; Zhao X; Yin L; Xu L; Qi Y; Xu Y; Han X; Liu K; Peng J
    Pharmacol Res; 2019 Jan; 139():431-439. PubMed ID: 30503840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
    Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
    Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin.
    Raju J; Mehta R
    Nutr Cancer; 2009; 61(1):27-35. PubMed ID: 19116873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.
    Wang Y; He QY; Chiu JF
    Eur J Pharmacol; 2014 Jul; 735():52-8. PubMed ID: 24755146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
    Yin L; Zheng L; Xu L; Dong D; Han X; Qi Y; Zhao Y; Xu Y; Peng J
    BMC Complement Altern Med; 2015 Mar; 15():41. PubMed ID: 25879470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cytotoxicity, and hemolytic activity of 6'-O-substituted dioscin derivatives.
    Li W; Qiu Z; Wang Y; Zhang Y; Li M; Yu J; Zhang L; Zhu Z; Yu B
    Carbohydr Res; 2007 Dec; 342(18):2705-15. PubMed ID: 17945208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.